Angioedema Treatment Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3200/- USD | Published Date: October 8, 2020 |

The global angioedema market has been projected to grow at the CAGR of 6.77% market during 2020-2027. Angioedema, also known as angioneurotic edema, is basically the rapid swelling dermis, subcutaneous tissue, sub mucosal and mucosa tissues. Angioedema is one of the common conditions caused due to allergies caused due genetic reasons, food, medication, environmental factors, and common allergens. There are four common forms of angioedema such as drug-induced angioedema allergic angioedema, idiopathic angioedema, and hereditary angioedema. The treatments for angioedema includes drug prescription for the prevention of allergic reactions in the patient.

Market Insights:

Rising numbers of angioedema patients is the key driver for global angioedema market. The treatment types include antihistamines, corticosteroids, autoimmune drugs, anti-fibrinolytic agents and blood protein controllers. Antihistamines and corticosteroids accounted for over 45% of the total market share because they are prescribed as the first line therapies and majorly used as supportive therapies and most accessible source of treatment across the globe. Despite the high cost of new treatment options in comparison to older therapies such as androgens and anti-fibrinolytic agents, they are popular with medical practitioner as it is very effective in the attenuation of the symptoms such as subcutaneous and abdominal swelling. Hence, introduction of new drugs with further improved effectiveness and safety will drive the global angioedema market during the forecast period. The global angioedema market is currently dominated by North America due to increasing number of angioedema patients, rising public awareness and early disease diagnosis and supportive reimbursement scenario. Asia Pacific is anticipated to be the fastest growing market for angioedema; the driving factors are lucrative investment opportunities to manufacturers of angioedema treatment drugs, increasing number of angioedema patients and developed healthcare infrastructure.

Market Segment Insights:

The global angioedema market is segmented by treatment such as antihistamines, corticosteroid, autoimmune drugs, anti-fibrinolytic agents and blood protein controller. The antihistamine and corticosteroid accounted for over 45% of the market revenue as these are the first line therapies preferred by medical practitioners and majorly used as supportive therapies and most accessible source of treatment across the globe.

Global Angioedema Market Segmentation:

By Treatment, 2018–2027 ($ Millon)

  • Antihistamines
  • Corticosteroids
  • Autoimmune Drugs
  • Anti-fibrinolytic Agents
  • Blood Protein Controllers

By Geography, 2018-2027 ($ Millon)

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Regional Insights:

For the purpose of this study, the global angioedema market is regionally categorized into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa markets. These regional markets are further sub-segmented into top country level markets that majorly determine the regional industry trends. Among the considered regional markets, North America currently dominates the global angioedema market, with United Sates being the largest county-level market. Increase in prevalence of angioedema patients, rising public awareness and supportive reimbursement policies.  On the other hand, Asia Pacific is anticipated to be the fastest growing market for angioedema; the driving factors are lucrative investment opportunities to manufacturers of angioedema treatment drugs, increasing number of angioedema patients and developed healthcare infrastructure.

Market Competition Assessment:

Key players in the global angioedema market are: AstraZeneca plc. Hoffman-La Roche AG, Valeant Pharmaceuticals International, Merck and Co., Dyax Corp., CSL Behring, Pharming group, ViroPharma and other notable players.

List of Key Companies:

  • AstraZeneca plc
  • Hoffmann-La Roche AG
  • Valeant Pharmaceuticals International
  • Merck & Co.
  • Dyax Corp.
  • CSL Behring
  • Pharming Group
  • ViroPharma
  • Other Notable Players

Key Questions Answered by Angioedema Treatment Market Report

  • Global angioedema treatment market forecasts from 2020-2027
  • Regional angioedema treatment market forecasts from 2020-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country level forecasts from 2020-2027 covering 15 major countries from aforementioned regions
  • Angioedema Treatment submarket forecasts from 2020-2027 covering submarket 1, submarket 2 submarket 3
  • Various industry models such as SWOT analysis, Pestle Analysis, Porter’s Five Force model, Value Chain Analysis pertaining to angioedema market
  • Analysis of the key factors driving and restraining the growth of the global, regional and country level angioedema treatment markets from 2020-2027
  • Competitive Landscape and market positioning of top 10 players operating in the angioedema treatment market

Request a full report sample in PDF format @ https://www.researchcorridor.com/request-sample/?id=39577


Table of Content:


Chapter 1 Preface


1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Methodology

Chapter 2 Executive Summary


2.1 Global Angioedema Treatment Market Portraiture
2.2 Global Angioedema Treatment Market, by Treatment, 2019 ($ Million)
2.3 Angioedema Treatment Market Share, by Geography, 2019 (Value %)

Chapter 3 Angioedema Treatment: Market Dynamics and Outlook


3.1 Introduction, Facts and Figures
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Rising Geriatric Population
3.2.1.2 Government Initiative
3.2.2 Challenges
3.2.2.1 Slow Responding Commercialization of New & Effective Therapies
3.2.3 Opportunities
3.2.3.1 Technological Advancements
3.3 Attractive Investment Proposition
3.4 Competitive Analysis
3.4.1 Market Share Analysis by Key Players, 2019 (Value %)

Chapter 4 Global Angioedema Treatment Market, by Treatment, 2018-2027 ($ Million)


4.1 Preface
4.2 Antihistamines
4.3 Corticosteroids
4.4 Autoimmune Drugs
4.5 Anti-fibrinolytic Agents
4.6 Blood Protein Controllers

Chapter 5 Global Angioedema Treatment Market, by Pipeline Treatment Analysis 2018-2027 ($ Million)


5.1 Overview
5.2 Phase I
5.3 Phase II
5.4 Phase III

Chapter 6 Global Angioedema Treatment Market, by Geography 2018-2027 ($ Million)


6.1 Overview
6.2 North America
6.2.1. U.S.
6.2.2. Canada
6.3 Europe
6.3.1. U.K.
6.3.2. Germany
6.3.3. Rest of Europe
6.4 Asia Pacific
6.4.1. Japan
6.4.2. China
6.4.3. Rest of Asia Pacific
6.5 Latin America
6.6 Middle East and Africa

Chapter 7 Company Profiles


7.1 AstraZeneca plc
7.2 F. Hoffmann-La Roche AG
7.3 Valeant Pharmaceuticals International.
7.4 Merck & Co.
7.5 Dyax Corp
7.6 CSL Behring
7.7 Pharming Group
7.8 ViroPharma
7.9 Other Notable Players

(Reports will be updated due to COVID-19 impacts on the market)

Request Report Sample
Inquiry Before Buying
Fill the given form to request sample for Angioedema Treatment Market Report

Your Designtaion (required):

Fill the given form to inquiry before buying for Angioedema Treatment Market Report

Your Designtaion (required):

Select License Type
$3200/- Single User License
$4800/- Multi User License
$6400/- Corporate License

Why To Choose Us:
  • Markets in over 150 countries analyzed granularly
  • 35% of our total client base has an annual subscription membership
  • 24x7 availability we are always there when you need us
  • 100,000+ data points in our comprehensive database
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report
  • We focus on the accuracy and quality of the report
  • Our analyst will provide deep insights into the report
For Any Assitance
Call Us: +919893685690
Contact Person: Mr. Vijendra Singh
Contact Email: sales@researchcorridor.com